New hope for inoperable esophageal cancer? drug combo trial underway
NCT ID NCT06281886
Summary
This study is testing whether adding a drug called apatinib to standard cancer treatment helps people with advanced esophageal cancer that cannot be removed by surgery. About 170 participants will be randomly assigned to receive the standard treatment alone or the standard treatment plus apatinib. The main goal is to see if the new combination helps keep the cancer from growing for a longer period of time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.